nodes	percent_of_prediction	percent_of_DWPC	metapath
Fludarabine—SLC29A1—pancreatic cancer	0.34	1	CbGaD
Fludarabine—Cytarabine—Gemcitabine—pancreatic cancer	0.0984	0.513	CrCrCtD
Fludarabine—Azacitidine—Gemcitabine—pancreatic cancer	0.0935	0.487	CrCrCtD
Fludarabine—RRM1—Gemcitabine—pancreatic cancer	0.0808	0.231	CbGbCtD
Fludarabine—POLA1—Gemcitabine—pancreatic cancer	0.0698	0.2	CbGbCtD
Fludarabine—SLC28A3—Gemcitabine—pancreatic cancer	0.0698	0.2	CbGbCtD
Fludarabine—SLC29A1—Gemcitabine—pancreatic cancer	0.0464	0.133	CbGbCtD
Fludarabine—DCK—Gemcitabine—pancreatic cancer	0.043	0.123	CbGbCtD
Fludarabine—SLC29A1—Fluorouracil—pancreatic cancer	0.0397	0.114	CbGbCtD
Fludarabine—SLC28A3—Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane—SLC29A1—pancreatic cancer	0.00845	0.225	CbGpPWpGaD
Fludarabine—SLC28A3—Transport of vitamins, nucleosides, and related molecules—SLC29A1—pancreatic cancer	0.00218	0.058	CbGpPWpGaD
Fludarabine—DCK—Pyrimidine salvage reactions—TYMP—pancreatic cancer	0.00218	0.0578	CbGpPWpGaD
Fludarabine—RRM1—Fluoropyrimidine Activity—SLC29A1—pancreatic cancer	0.00199	0.0529	CbGpPWpGaD
Fludarabine—SLC28A3—islet of Langerhans—pancreatic cancer	0.00143	0.178	CbGeAlD
Fludarabine—SLC28A3—pancreas—pancreatic cancer	0.00101	0.125	CbGeAlD
Fludarabine—RRM1—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.001	0.0266	CbGpPWpGaD
Fludarabine—DCK—Pyrimidine metabolism—TYMP—pancreatic cancer	0.000993	0.0264	CbGpPWpGaD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—TYMP—pancreatic cancer	0.000915	0.0243	CbGpPWpGaD
Fludarabine—SLC28A3—digestive system—pancreatic cancer	0.000861	0.107	CbGeAlD
Fludarabine—RRM1—islet of Langerhans—pancreatic cancer	0.0008	0.0991	CbGeAlD
Fludarabine—RRM1—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000794	0.0211	CbGpPWpGaD
Fludarabine—DCK—Pyrimidine metabolism—DPYD—pancreatic cancer	0.000788	0.0209	CbGpPWpGaD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—DPYD—pancreatic cancer	0.000726	0.0193	CbGpPWpGaD
Fludarabine—DCK—Topotecan—Irinotecan—pancreatic cancer	0.00067	0.44	CbGdCrCtD
Fludarabine—RRM1—E2F transcription factor network—RBBP8—pancreatic cancer	0.000663	0.0176	CbGpPWpGaD
Fludarabine—SLC29A1—islet of Langerhans—pancreatic cancer	0.00065	0.0805	CbGeAlD
Fludarabine—DCK—islet of Langerhans—pancreatic cancer	0.000621	0.0769	CbGeAlD
Fludarabine—RRM1—pancreas—pancreatic cancer	0.000562	0.0696	CbGeAlD
Fludarabine—Ribavirin—SLC29A1—pancreatic cancer	0.000551	0.206	CrCbGaD
Fludarabine—RRM1—Nucleotide metabolism—TYMP—pancreatic cancer	0.000503	0.0134	CbGpPWpGaD
Fludarabine—RRM1—digestive system—pancreatic cancer	0.00048	0.0595	CbGeAlD
Fludarabine—SLC28A3—SLC-mediated transmembrane transport—SLC29A1—pancreatic cancer	0.000469	0.0125	CbGpPWpGaD
Fludarabine—SLC29A1—pancreas—pancreatic cancer	0.000457	0.0566	CbGeAlD
Fludarabine—RRM1—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000452	0.012	CbGpPWpGaD
Fludarabine—DCK—Pyrimidine metabolism—TYMS—pancreatic cancer	0.000449	0.0119	CbGpPWpGaD
Fludarabine—DCK—pancreas—pancreatic cancer	0.000437	0.0541	CbGeAlD
Fludarabine—POLA1—G1/S-Specific Transcription—TYMS—pancreatic cancer	0.000433	0.0115	CbGpPWpGaD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—TYMS—pancreatic cancer	0.000414	0.011	CbGpPWpGaD
Fludarabine—Adenosine triphosphate—HSPA1B—pancreatic cancer	0.000403	0.151	CrCbGaD
Fludarabine—Adenosine triphosphate—ACVR1B—pancreatic cancer	0.000403	0.151	CrCbGaD
Fludarabine—RRM1—Nucleotide metabolism—DPYD—pancreatic cancer	0.000399	0.0106	CbGpPWpGaD
Fludarabine—SLC29A1—digestive system—pancreatic cancer	0.00039	0.0484	CbGeAlD
Fludarabine—POLA1—Inhibition of replication initiation of damaged DNA by RB1/E2F1—RB1—pancreatic cancer	0.000388	0.0103	CbGpPWpGaD
Fludarabine—DCK—Nucleotide metabolism—TYMP—pancreatic cancer	0.000387	0.0103	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.000387	0.0103	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—RBBP8—pancreatic cancer	0.000374	0.00992	CbGpPWpGaD
Fludarabine—DCK—digestive system—pancreatic cancer	0.000373	0.0462	CbGeAlD
Fludarabine—Adenosine triphosphate—HSPA1A—pancreatic cancer	0.000369	0.138	CrCbGaD
Fludarabine—Cytarabine—SLC29A1—pancreatic cancer	0.000357	0.134	CrCbGaD
Fludarabine—RRM1—Azacitidine—Gemcitabine—pancreatic cancer	0.000342	0.225	CbGdCrCtD
Fludarabine—DCK—Nucleotide metabolism—DPYD—pancreatic cancer	0.000307	0.00815	CbGpPWpGaD
Fludarabine—Flavin adenine dinucleotide—DPYD—pancreatic cancer	0.000301	0.113	CrCbGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000292	0.00777	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000281	0.00746	CbGpPWpGaD
Fludarabine—POLA1—E2F mediated regulation of DNA replication—TYMS—pancreatic cancer	0.000255	0.00677	CbGpPWpGaD
Fludarabine—POLA1—Extension of Telomeres—TERT—pancreatic cancer	0.000246	0.00654	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—TYMS—pancreatic cancer	0.00024	0.00636	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—SLC29A1—pancreatic cancer	0.000238	0.00633	CbGpPWpGaD
Fludarabine—RRM1—Nucleotide metabolism—TYMS—pancreatic cancer	0.000227	0.00604	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—FXYD3—pancreatic cancer	0.000218	0.00579	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TFF1—pancreatic cancer	0.000218	0.00579	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—TYMS—pancreatic cancer	0.000208	0.00553	CbGpPWpGaD
Fludarabine—DCK—Clomifene—Tamoxifen—pancreatic cancer	0.000206	0.136	CbGdCrCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.000198	0.00526	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—PLAU—pancreatic cancer	0.000198	0.00525	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.000178	0.00472	CbGpPWpGaD
Fludarabine—SLC28A3—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000177	0.00471	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	0.000175	0.00466	CbGpPWpGaD
Fludarabine—DCK—Nucleotide metabolism—TYMS—pancreatic cancer	0.000175	0.00464	CbGpPWpGaD
Fludarabine—POLA1—E2F mediated regulation of DNA replication—RB1—pancreatic cancer	0.000173	0.00459	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—RB1—pancreatic cancer	0.000162	0.00431	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—TYMS—pancreatic cancer	0.00016	0.00426	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—DAXX—pancreatic cancer	0.000158	0.0042	CbGpPWpGaD
Fludarabine—DCK—Doxorubicin—Epirubicin—pancreatic cancer	0.000158	0.104	CbGdCrCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	0.000153	0.00407	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	0.000151	0.004	CbGpPWpGaD
Fludarabine—RRM1—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.00015	0.00398	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—SYCP1—pancreatic cancer	0.000146	0.00389	CbGpPWpGaD
Fludarabine—DCK—Epirubicin—Doxorubicin—pancreatic cancer	0.000146	0.0958	CbGdCrCtD
Fludarabine—Adenosine triphosphate—AKT1—pancreatic cancer	0.000145	0.0541	CrCbGaD
Fludarabine—RRM1—E2F transcription factor network—CDKN2A—pancreatic cancer	0.000143	0.00379	CbGpPWpGaD
Fludarabine—Adenosine monophosphate—SRC—pancreatic cancer	0.000143	0.0533	CrCbGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	0.000141	0.00375	CbGpPWpGaD
Fludarabine—SLC29A1—Fluoropyrimidine Activity—TP53—pancreatic cancer	0.000137	0.00364	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—TYMS—pancreatic cancer	0.000135	0.00358	CbGpPWpGaD
Fludarabine—SLC29A1—SLC-mediated transmembrane transport—SLC2A2—pancreatic cancer	0.000132	0.00351	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	0.000129	0.00343	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—TYMS—pancreatic cancer	0.000117	0.00312	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	0.000117	0.0031	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	0.000113	0.003	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—WT1—pancreatic cancer	0.000112	0.00296	CbGpPWpGaD
Fludarabine—POLA1—Telomere Maintenance—TERT—pancreatic cancer	0.000111	0.00296	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—PLAU—pancreatic cancer	0.000111	0.00296	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	0.000111	0.00295	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	0.000109	0.00289	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	0.000105	0.00278	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—SHH—pancreatic cancer	0.0001	0.00266	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—IAPP—pancreatic cancer	9.88e-05	0.00262	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—TYMS—pancreatic cancer	9.79e-05	0.0026	CbGpPWpGaD
Fludarabine—RRM1—E2F transcription factor network—MYC—pancreatic cancer	9.68e-05	0.00257	CbGpPWpGaD
Fludarabine—POLA1—Chromosome Maintenance—TERT—pancreatic cancer	9.29e-05	0.00247	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—RB1—pancreatic cancer	9.15e-05	0.00243	CbGpPWpGaD
Fludarabine—SLC28A3—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	9e-05	0.00239	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—PPP2R5B—pancreatic cancer	8.71e-05	0.00231	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EZH2—pancreatic cancer	8.63e-05	0.00229	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—GADD45A—pancreatic cancer	8.49e-05	0.00225	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	8.41e-05	0.00223	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	8.41e-05	0.00223	CbGpPWpGaD
Fludarabine—POLA1—Mitotic G1-G1/S phases—TYMS—pancreatic cancer	8.25e-05	0.00219	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	8.07e-05	0.00214	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	8.05e-05	0.00214	CbGpPWpGaD
Fludarabine—POLA1—E2F transcription factor network—CDKN2A—pancreatic cancer	8.04e-05	0.00214	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—RB1—pancreatic cancer	7.95e-05	0.00211	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—RBBP8—pancreatic cancer	7.49e-05	0.00199	CbGpPWpGaD
Fludarabine—POLA1—Synthesis of DNA—RB1—pancreatic cancer	7.35e-05	0.00195	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—STK11—pancreatic cancer	7.27e-05	0.00193	CbGpPWpGaD
Fludarabine—RRM1—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	6.91e-05	0.00183	CbGpPWpGaD
Fludarabine—POLA1—DNA Replication—RB1—pancreatic cancer	6.89e-05	0.00183	CbGpPWpGaD
Fludarabine—SLC29A1—Transmembrane transport of small molecules—SLC2A2—pancreatic cancer	6.71e-05	0.00178	CbGpPWpGaD
Fludarabine—POLA1—G1/S Transition—RB1—pancreatic cancer	6.64e-05	0.00176	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—BRCA2—pancreatic cancer	6.57e-05	0.00175	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—PPP2R5B—pancreatic cancer	6.52e-05	0.00173	CbGpPWpGaD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	6.47e-05	0.00172	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—SMAD4—pancreatic cancer	6.37e-05	0.00169	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TYMS—pancreatic cancer	6.25e-05	0.00166	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	6.19e-05	0.00164	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PRSS1—pancreatic cancer	6.03e-05	0.0016	CbGpPWpGaD
Fludarabine—POLA1—S Phase—RB1—pancreatic cancer	6.03e-05	0.0016	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—CCND1—pancreatic cancer	5.9e-05	0.00157	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—PPP2R5B—pancreatic cancer	5.83e-05	0.00155	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—FOXM1—pancreatic cancer	5.81e-05	0.00154	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	5.74e-05	0.00153	CbGpPWpGaD
Fludarabine—Erythema multiforme—Docetaxel—pancreatic cancer	5.65e-05	0.00082	CcSEcCtD
Fludarabine—Anorexia—Fluorouracil—pancreatic cancer	5.61e-05	0.000814	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—RB1—pancreatic cancer	5.59e-05	0.00149	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	5.59e-05	0.00148	CbGpPWpGaD
Fludarabine—Vomiting—Tamoxifen—pancreatic cancer	5.54e-05	0.000803	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	5.53e-05	0.00147	CbGpPWpGaD
Fludarabine—Cardiac failure—Doxorubicin—pancreatic cancer	5.53e-05	0.000802	CcSEcCtD
Fludarabine—Paraesthesia—Irinotecan—pancreatic cancer	5.52e-05	0.0008	CcSEcCtD
Fludarabine—Cerebrovascular accident—Doxorubicin—pancreatic cancer	5.5e-05	0.000798	CcSEcCtD
Fludarabine—Hypersensitivity—Sunitinib—pancreatic cancer	5.5e-05	0.000797	CcSEcCtD
Fludarabine—Rash—Tamoxifen—pancreatic cancer	5.49e-05	0.000797	CcSEcCtD
Fludarabine—Dermatitis—Tamoxifen—pancreatic cancer	5.49e-05	0.000796	CcSEcCtD
Fludarabine—Vomiting—Erlotinib—pancreatic cancer	5.48e-05	0.000795	CcSEcCtD
Fludarabine—Dyspnoea—Irinotecan—pancreatic cancer	5.48e-05	0.000795	CcSEcCtD
Fludarabine—Headache—Tamoxifen—pancreatic cancer	5.46e-05	0.000791	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Gemcitabine—pancreatic cancer	5.45e-05	0.000791	CcSEcCtD
Fludarabine—POLA1—E2F transcription factor network—MYC—pancreatic cancer	5.45e-05	0.00145	CbGpPWpGaD
Fludarabine—Rash—Erlotinib—pancreatic cancer	5.43e-05	0.000788	CcSEcCtD
Fludarabine—Dermatitis—Erlotinib—pancreatic cancer	5.43e-05	0.000787	CcSEcCtD
Fludarabine—Dehydration—Epirubicin—pancreatic cancer	5.42e-05	0.000786	CcSEcCtD
Fludarabine—Dyspepsia—Irinotecan—pancreatic cancer	5.41e-05	0.000785	CcSEcCtD
Fludarabine—Headache—Erlotinib—pancreatic cancer	5.4e-05	0.000783	CcSEcCtD
Fludarabine—Gastrointestinal haemorrhage—Doxorubicin—pancreatic cancer	5.39e-05	0.000782	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	5.39e-05	0.00143	CbGpPWpGaD
Fludarabine—Liver function test abnormal—Epirubicin—pancreatic cancer	5.38e-05	0.000781	CcSEcCtD
Fludarabine—Paraesthesia—Gemcitabine—pancreatic cancer	5.38e-05	0.00078	CcSEcCtD
Fludarabine—Chills—Docetaxel—pancreatic cancer	5.37e-05	0.000778	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Fluorouracil—pancreatic cancer	5.36e-05	0.000778	CcSEcCtD
Fludarabine—Asthenia—Sunitinib—pancreatic cancer	5.35e-05	0.000776	CcSEcCtD
Fludarabine—Decreased appetite—Irinotecan—pancreatic cancer	5.34e-05	0.000775	CcSEcCtD
Fludarabine—Arrhythmia—Docetaxel—pancreatic cancer	5.34e-05	0.000775	CcSEcCtD
Fludarabine—Dyspnoea—Gemcitabine—pancreatic cancer	5.34e-05	0.000774	CcSEcCtD
Fludarabine—DCK—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	5.31e-05	0.00141	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Irinotecan—pancreatic cancer	5.31e-05	0.000769	CcSEcCtD
Fludarabine—Fatigue—Irinotecan—pancreatic cancer	5.3e-05	0.000768	CcSEcCtD
Fludarabine—Paraesthesia—Fluorouracil—pancreatic cancer	5.29e-05	0.000766	CcSEcCtD
Fludarabine—Alopecia—Docetaxel—pancreatic cancer	5.28e-05	0.000766	CcSEcCtD
Fludarabine—Pruritus—Sunitinib—pancreatic cancer	5.28e-05	0.000765	CcSEcCtD
Fludarabine—Constipation—Irinotecan—pancreatic cancer	5.26e-05	0.000762	CcSEcCtD
Fludarabine—Pain—Irinotecan—pancreatic cancer	5.26e-05	0.000762	CcSEcCtD
Fludarabine—Toxic epidermal necrolysis—Epirubicin—pancreatic cancer	5.25e-05	0.000761	CcSEcCtD
Fludarabine—Dyspnoea—Fluorouracil—pancreatic cancer	5.25e-05	0.000761	CcSEcCtD
Fludarabine—RRM1—Metabolism—ARG2—pancreatic cancer	5.23e-05	0.00139	CbGpPWpGaD
Fludarabine—Malnutrition—Docetaxel—pancreatic cancer	5.21e-05	0.000755	CcSEcCtD
Fludarabine—Decreased appetite—Gemcitabine—pancreatic cancer	5.2e-05	0.000755	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—FOXM1—pancreatic cancer	5.19e-05	0.00138	CbGpPWpGaD
Fludarabine—Dyspepsia—Fluorouracil—pancreatic cancer	5.18e-05	0.000751	CcSEcCtD
Fludarabine—Nausea—Tamoxifen—pancreatic cancer	5.17e-05	0.00075	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Gemcitabine—pancreatic cancer	5.17e-05	0.00075	CcSEcCtD
Fludarabine—Fatigue—Gemcitabine—pancreatic cancer	5.16e-05	0.000748	CcSEcCtD
Fludarabine—Constipation—Gemcitabine—pancreatic cancer	5.12e-05	0.000742	CcSEcCtD
Fludarabine—Pain—Gemcitabine—pancreatic cancer	5.12e-05	0.000742	CcSEcCtD
Fludarabine—Nausea—Erlotinib—pancreatic cancer	5.12e-05	0.000742	CcSEcCtD
Fludarabine—Decreased appetite—Fluorouracil—pancreatic cancer	5.12e-05	0.000742	CcSEcCtD
Fludarabine—Diarrhoea—Sunitinib—pancreatic cancer	5.1e-05	0.00074	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Fluorouracil—pancreatic cancer	5.08e-05	0.000737	CcSEcCtD
Fludarabine—Feeling abnormal—Irinotecan—pancreatic cancer	5.06e-05	0.000734	CcSEcCtD
Fludarabine—Dysphagia—Epirubicin—pancreatic cancer	5.04e-05	0.000731	CcSEcCtD
Fludarabine—Pain—Fluorouracil—pancreatic cancer	5.03e-05	0.00073	CcSEcCtD
Fludarabine—Dehydration—Doxorubicin—pancreatic cancer	5.02e-05	0.000728	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	5e-05	0.00133	CbGpPWpGaD
Fludarabine—Liver function test abnormal—Doxorubicin—pancreatic cancer	4.98e-05	0.000722	CcSEcCtD
Fludarabine—Feeling abnormal—Gemcitabine—pancreatic cancer	4.93e-05	0.000715	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CDKN2A—pancreatic cancer	4.92e-05	0.00131	CbGpPWpGaD
Fludarabine—Angina pectoris—Epirubicin—pancreatic cancer	4.91e-05	0.000712	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	4.87e-05	0.00129	CbGpPWpGaD
Fludarabine—Body temperature increased—Irinotecan—pancreatic cancer	4.86e-05	0.000705	CcSEcCtD
Fludarabine—Toxic epidermal necrolysis—Doxorubicin—pancreatic cancer	4.86e-05	0.000704	CcSEcCtD
Fludarabine—Feeling abnormal—Fluorouracil—pancreatic cancer	4.85e-05	0.000703	CcSEcCtD
Fludarabine—Bronchitis—Epirubicin—pancreatic cancer	4.85e-05	0.000703	CcSEcCtD
Fludarabine—Anaemia—Docetaxel—pancreatic cancer	4.81e-05	0.000698	CcSEcCtD
Fludarabine—Pancytopenia—Epirubicin—pancreatic cancer	4.79e-05	0.000694	CcSEcCtD
Fludarabine—Vomiting—Sunitinib—pancreatic cancer	4.74e-05	0.000688	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—NFKBIA—pancreatic cancer	4.74e-05	0.00126	CbGpPWpGaD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—MYC—pancreatic cancer	4.74e-05	0.00126	CbGpPWpGaD
Fludarabine—Body temperature increased—Gemcitabine—pancreatic cancer	4.73e-05	0.000686	CcSEcCtD
Fludarabine—Neutropenia—Epirubicin—pancreatic cancer	4.71e-05	0.000683	CcSEcCtD
Fludarabine—Dysuria—Epirubicin—pancreatic cancer	4.71e-05	0.000683	CcSEcCtD
Fludarabine—Rash—Sunitinib—pancreatic cancer	4.7e-05	0.000682	CcSEcCtD
Fludarabine—Dermatitis—Sunitinib—pancreatic cancer	4.7e-05	0.000682	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Epirubicin—pancreatic cancer	4.68e-05	0.000679	CcSEcCtD
Fludarabine—Headache—Sunitinib—pancreatic cancer	4.67e-05	0.000678	CcSEcCtD
Fludarabine—Dysphagia—Doxorubicin—pancreatic cancer	4.66e-05	0.000676	CcSEcCtD
Fludarabine—Leukopenia—Docetaxel—pancreatic cancer	4.66e-05	0.000676	CcSEcCtD
Fludarabine—Body temperature increased—Fluorouracil—pancreatic cancer	4.65e-05	0.000675	CcSEcCtD
Fludarabine—DCK—Metabolism—PRSS1—pancreatic cancer	4.64e-05	0.00123	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—TYMP—pancreatic cancer	4.57e-05	0.00121	CbGpPWpGaD
Fludarabine—Hyperglycaemia—Epirubicin—pancreatic cancer	4.55e-05	0.000659	CcSEcCtD
Fludarabine—Cough—Docetaxel—pancreatic cancer	4.54e-05	0.000659	CcSEcCtD
Fludarabine—Angina pectoris—Doxorubicin—pancreatic cancer	4.54e-05	0.000659	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGF—pancreatic cancer	4.54e-05	0.0012	CbGpPWpGaD
Fludarabine—Hypersensitivity—Irinotecan—pancreatic cancer	4.53e-05	0.000657	CcSEcCtD
Fludarabine—Pneumonia—Epirubicin—pancreatic cancer	4.52e-05	0.000655	CcSEcCtD
Fludarabine—Convulsion—Docetaxel—pancreatic cancer	4.51e-05	0.000654	CcSEcCtD
Fludarabine—Bronchitis—Doxorubicin—pancreatic cancer	4.48e-05	0.00065	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	4.48e-05	0.00119	CbGpPWpGaD
Fludarabine—POLA1—S Phase—CCND1—pancreatic cancer	4.48e-05	0.00119	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	4.47e-05	0.00119	CbGpPWpGaD
Fludarabine—Stevens-Johnson syndrome—Epirubicin—pancreatic cancer	4.45e-05	0.000646	CcSEcCtD
Fludarabine—Myalgia—Docetaxel—pancreatic cancer	4.43e-05	0.000643	CcSEcCtD
Fludarabine—Arthralgia—Docetaxel—pancreatic cancer	4.43e-05	0.000643	CcSEcCtD
Fludarabine—Nausea—Sunitinib—pancreatic cancer	4.43e-05	0.000643	CcSEcCtD
Fludarabine—Pancytopenia—Doxorubicin—pancreatic cancer	4.43e-05	0.000642	CcSEcCtD
Fludarabine—Renal failure—Epirubicin—pancreatic cancer	4.42e-05	0.00064	CcSEcCtD
Fludarabine—Asthenia—Irinotecan—pancreatic cancer	4.41e-05	0.000639	CcSEcCtD
Fludarabine—Neuropathy peripheral—Epirubicin—pancreatic cancer	4.4e-05	0.000639	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	4.38e-05	0.00116	CbGpPWpGaD
Fludarabine—Stomatitis—Epirubicin—pancreatic cancer	4.38e-05	0.000635	CcSEcCtD
Fludarabine—Urinary tract infection—Epirubicin—pancreatic cancer	4.37e-05	0.000633	CcSEcCtD
Fludarabine—Dysuria—Doxorubicin—pancreatic cancer	4.36e-05	0.000632	CcSEcCtD
Fludarabine—Neutropenia—Doxorubicin—pancreatic cancer	4.36e-05	0.000632	CcSEcCtD
Fludarabine—Hypersensitivity—Fluorouracil—pancreatic cancer	4.34e-05	0.000629	CcSEcCtD
Fludarabine—Upper respiratory tract infection—Doxorubicin—pancreatic cancer	4.33e-05	0.000628	CcSEcCtD
Fludarabine—Asthenia—Gemcitabine—pancreatic cancer	4.3e-05	0.000623	CcSEcCtD
Fludarabine—Haematuria—Epirubicin—pancreatic cancer	4.28e-05	0.000621	CcSEcCtD
Fludarabine—Confusional state—Docetaxel—pancreatic cancer	4.28e-05	0.000621	CcSEcCtD
Fludarabine—Anaphylactic shock—Docetaxel—pancreatic cancer	4.25e-05	0.000616	CcSEcCtD
Fludarabine—Oedema—Docetaxel—pancreatic cancer	4.25e-05	0.000616	CcSEcCtD
Fludarabine—Epistaxis—Epirubicin—pancreatic cancer	4.24e-05	0.000615	CcSEcCtD
Fludarabine—Pruritus—Gemcitabine—pancreatic cancer	4.24e-05	0.000614	CcSEcCtD
Fludarabine—Infection—Docetaxel—pancreatic cancer	4.22e-05	0.000612	CcSEcCtD
Fludarabine—Sinusitis—Epirubicin—pancreatic cancer	4.22e-05	0.000611	CcSEcCtD
Fludarabine—Hyperglycaemia—Doxorubicin—pancreatic cancer	4.21e-05	0.00061	CcSEcCtD
Fludarabine—Diarrhoea—Irinotecan—pancreatic cancer	4.2e-05	0.00061	CcSEcCtD
Fludarabine—Pneumonia—Doxorubicin—pancreatic cancer	4.18e-05	0.000606	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	4.18e-05	0.00111	CbGpPWpGaD
Fludarabine—Nervous system disorder—Docetaxel—pancreatic cancer	4.17e-05	0.000604	CcSEcCtD
Fludarabine—Pruritus—Fluorouracil—pancreatic cancer	4.16e-05	0.000604	CcSEcCtD
Fludarabine—Thrombocytopenia—Docetaxel—pancreatic cancer	4.16e-05	0.000603	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—CCND1—pancreatic cancer	4.15e-05	0.0011	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	4.14e-05	0.0011	CbGpPWpGaD
Fludarabine—Stevens-Johnson syndrome—Doxorubicin—pancreatic cancer	4.12e-05	0.000598	CcSEcCtD
Fludarabine—Diarrhoea—Gemcitabine—pancreatic cancer	4.1e-05	0.000594	CcSEcCtD
Fludarabine—Renal failure—Doxorubicin—pancreatic cancer	4.09e-05	0.000593	CcSEcCtD
Fludarabine—Neuropathy peripheral—Doxorubicin—pancreatic cancer	4.07e-05	0.000591	CcSEcCtD
Fludarabine—Haemoglobin—Epirubicin—pancreatic cancer	4.05e-05	0.000588	CcSEcCtD
Fludarabine—Stomatitis—Doxorubicin—pancreatic cancer	4.05e-05	0.000588	CcSEcCtD
Fludarabine—Anorexia—Docetaxel—pancreatic cancer	4.05e-05	0.000587	CcSEcCtD
Fludarabine—Urinary tract infection—Doxorubicin—pancreatic cancer	4.04e-05	0.000586	CcSEcCtD
Fludarabine—Haemorrhage—Epirubicin—pancreatic cancer	4.03e-05	0.000585	CcSEcCtD
Fludarabine—Diarrhoea—Fluorouracil—pancreatic cancer	4.03e-05	0.000584	CcSEcCtD
Fludarabine—DCK—Metabolism—ARG2—pancreatic cancer	4.02e-05	0.00107	CbGpPWpGaD
Fludarabine—Hypoaesthesia—Epirubicin—pancreatic cancer	4.01e-05	0.000582	CcSEcCtD
Fludarabine—Pharyngitis—Epirubicin—pancreatic cancer	4e-05	0.000581	CcSEcCtD
Fludarabine—Haematuria—Doxorubicin—pancreatic cancer	3.96e-05	0.000575	CcSEcCtD
Fludarabine—POLA1—G1/S Transition—MYC—pancreatic cancer	3.95e-05	0.00105	CbGpPWpGaD
Fludarabine—Epistaxis—Doxorubicin—pancreatic cancer	3.92e-05	0.000569	CcSEcCtD
Fludarabine—Vomiting—Irinotecan—pancreatic cancer	3.91e-05	0.000567	CcSEcCtD
Fludarabine—Sinusitis—Doxorubicin—pancreatic cancer	3.9e-05	0.000566	CcSEcCtD
Fludarabine—POLA1—Retinoblastoma (RB) in Cancer—TP53—pancreatic cancer	3.89e-05	0.00103	CbGpPWpGaD
Fludarabine—Visual impairment—Epirubicin—pancreatic cancer	3.89e-05	0.000564	CcSEcCtD
Fludarabine—Rash—Irinotecan—pancreatic cancer	3.87e-05	0.000562	CcSEcCtD
Fludarabine—Dermatitis—Irinotecan—pancreatic cancer	3.87e-05	0.000561	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Docetaxel—pancreatic cancer	3.87e-05	0.000561	CcSEcCtD
Fludarabine—Headache—Irinotecan—pancreatic cancer	3.85e-05	0.000558	CcSEcCtD
Fludarabine—Paraesthesia—Docetaxel—pancreatic cancer	3.81e-05	0.000553	CcSEcCtD
Fludarabine—Erythema multiforme—Epirubicin—pancreatic cancer	3.81e-05	0.000553	CcSEcCtD
Fludarabine—Vomiting—Gemcitabine—pancreatic cancer	3.81e-05	0.000552	CcSEcCtD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	3.81e-05	0.00101	CbGpPWpGaD
Fludarabine—Dyspnoea—Docetaxel—pancreatic cancer	3.79e-05	0.000549	CcSEcCtD
Fludarabine—Rash—Gemcitabine—pancreatic cancer	3.77e-05	0.000547	CcSEcCtD
Fludarabine—Dermatitis—Gemcitabine—pancreatic cancer	3.77e-05	0.000547	CcSEcCtD
Fludarabine—Haemoglobin—Doxorubicin—pancreatic cancer	3.75e-05	0.000544	CcSEcCtD
Fludarabine—Headache—Gemcitabine—pancreatic cancer	3.75e-05	0.000544	CcSEcCtD
Fludarabine—Vomiting—Fluorouracil—pancreatic cancer	3.74e-05	0.000543	CcSEcCtD
Fludarabine—Dyspepsia—Docetaxel—pancreatic cancer	3.74e-05	0.000542	CcSEcCtD
Fludarabine—Haemorrhage—Doxorubicin—pancreatic cancer	3.73e-05	0.000541	CcSEcCtD
Fludarabine—Hypoaesthesia—Doxorubicin—pancreatic cancer	3.71e-05	0.000538	CcSEcCtD
Fludarabine—Rash—Fluorouracil—pancreatic cancer	3.71e-05	0.000538	CcSEcCtD
Fludarabine—Dermatitis—Fluorouracil—pancreatic cancer	3.71e-05	0.000538	CcSEcCtD
Fludarabine—Pharyngitis—Doxorubicin—pancreatic cancer	3.7e-05	0.000537	CcSEcCtD
Fludarabine—Decreased appetite—Docetaxel—pancreatic cancer	3.69e-05	0.000536	CcSEcCtD
Fludarabine—Headache—Fluorouracil—pancreatic cancer	3.69e-05	0.000535	CcSEcCtD
Fludarabine—RRM1—Metabolism—GLP1R—pancreatic cancer	3.68e-05	0.000978	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	3.68e-05	0.000978	CbGpPWpGaD
Fludarabine—Gastrointestinal disorder—Docetaxel—pancreatic cancer	3.67e-05	0.000532	CcSEcCtD
Fludarabine—Fatigue—Docetaxel—pancreatic cancer	3.66e-05	0.000531	CcSEcCtD
Fludarabine—Nausea—Irinotecan—pancreatic cancer	3.65e-05	0.000529	CcSEcCtD
Fludarabine—Constipation—Docetaxel—pancreatic cancer	3.63e-05	0.000527	CcSEcCtD
Fludarabine—Pain—Docetaxel—pancreatic cancer	3.63e-05	0.000527	CcSEcCtD
Fludarabine—RRM1—Metabolism—DPYD—pancreatic cancer	3.62e-05	0.000962	CbGpPWpGaD
Fludarabine—Chills—Epirubicin—pancreatic cancer	3.62e-05	0.000525	CcSEcCtD
Fludarabine—Arrhythmia—Epirubicin—pancreatic cancer	3.6e-05	0.000523	CcSEcCtD
Fludarabine—Visual impairment—Doxorubicin—pancreatic cancer	3.6e-05	0.000522	CcSEcCtD
Fludarabine—POLA1—S Phase—MYC—pancreatic cancer	3.59e-05	0.000954	CbGpPWpGaD
Fludarabine—Alopecia—Epirubicin—pancreatic cancer	3.56e-05	0.000517	CcSEcCtD
Fludarabine—Nausea—Gemcitabine—pancreatic cancer	3.56e-05	0.000516	CcSEcCtD
Fludarabine—Erythema multiforme—Doxorubicin—pancreatic cancer	3.53e-05	0.000512	CcSEcCtD
Fludarabine—DCK—Metabolism—TYMP—pancreatic cancer	3.52e-05	0.000934	CbGpPWpGaD
Fludarabine—Malnutrition—Epirubicin—pancreatic cancer	3.51e-05	0.000509	CcSEcCtD
Fludarabine—Feeling abnormal—Docetaxel—pancreatic cancer	3.5e-05	0.000508	CcSEcCtD
Fludarabine—Nausea—Fluorouracil—pancreatic cancer	3.5e-05	0.000507	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTGS2—pancreatic cancer	3.48e-05	0.000925	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—SLC2A2—pancreatic cancer	3.44e-05	0.000913	CbGpPWpGaD
Fludarabine—Body temperature increased—Docetaxel—pancreatic cancer	3.36e-05	0.000487	CcSEcCtD
Fludarabine—Chills—Doxorubicin—pancreatic cancer	3.35e-05	0.000486	CcSEcCtD
Fludarabine—Arrhythmia—Doxorubicin—pancreatic cancer	3.33e-05	0.000483	CcSEcCtD
Fludarabine—POLA1—Mitotic G1-G1/S phases—MYC—pancreatic cancer	3.33e-05	0.000885	CbGpPWpGaD
Fludarabine—Alopecia—Doxorubicin—pancreatic cancer	3.3e-05	0.000478	CcSEcCtD
Fludarabine—Ill-defined disorder—Epirubicin—pancreatic cancer	3.26e-05	0.000472	CcSEcCtD
Fludarabine—Malnutrition—Doxorubicin—pancreatic cancer	3.25e-05	0.000471	CcSEcCtD
Fludarabine—Anaemia—Epirubicin—pancreatic cancer	3.25e-05	0.000471	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CASP3—pancreatic cancer	3.23e-05	0.000859	CbGpPWpGaD
Fludarabine—Agitation—Epirubicin—pancreatic cancer	3.23e-05	0.000468	CcSEcCtD
Fludarabine—Malaise—Epirubicin—pancreatic cancer	3.17e-05	0.000459	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CCND1—pancreatic cancer	3.15e-05	0.000836	CbGpPWpGaD
Fludarabine—Leukopenia—Epirubicin—pancreatic cancer	3.14e-05	0.000456	CcSEcCtD
Fludarabine—Hypersensitivity—Docetaxel—pancreatic cancer	3.13e-05	0.000454	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—CTNNB1—pancreatic cancer	3.12e-05	0.000828	CbGpPWpGaD
Fludarabine—RRM1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	3.11e-05	0.000826	CbGpPWpGaD
Fludarabine—Cough—Epirubicin—pancreatic cancer	3.06e-05	0.000444	CcSEcCtD
Fludarabine—Asthenia—Docetaxel—pancreatic cancer	3.05e-05	0.000442	CcSEcCtD
Fludarabine—Convulsion—Epirubicin—pancreatic cancer	3.04e-05	0.000441	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PTEN—pancreatic cancer	3.04e-05	0.000807	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—TYMS—pancreatic cancer	3.03e-05	0.000804	CbGpPWpGaD
Fludarabine—Ill-defined disorder—Doxorubicin—pancreatic cancer	3.01e-05	0.000437	CcSEcCtD
Fludarabine—Pruritus—Docetaxel—pancreatic cancer	3.01e-05	0.000436	CcSEcCtD
Fludarabine—Anaemia—Doxorubicin—pancreatic cancer	3e-05	0.000435	CcSEcCtD
Fludarabine—Myalgia—Epirubicin—pancreatic cancer	2.99e-05	0.000433	CcSEcCtD
Fludarabine—Arthralgia—Epirubicin—pancreatic cancer	2.99e-05	0.000433	CcSEcCtD
Fludarabine—Agitation—Doxorubicin—pancreatic cancer	2.99e-05	0.000433	CcSEcCtD
Fludarabine—Discomfort—Epirubicin—pancreatic cancer	2.95e-05	0.000428	CcSEcCtD
Fludarabine—Malaise—Doxorubicin—pancreatic cancer	2.93e-05	0.000425	CcSEcCtD
Fludarabine—Leukopenia—Doxorubicin—pancreatic cancer	2.91e-05	0.000422	CcSEcCtD
Fludarabine—Diarrhoea—Docetaxel—pancreatic cancer	2.91e-05	0.000422	CcSEcCtD
Fludarabine—Confusional state—Epirubicin—pancreatic cancer	2.89e-05	0.000419	CcSEcCtD
Fludarabine—Anaphylactic shock—Epirubicin—pancreatic cancer	2.87e-05	0.000416	CcSEcCtD
Fludarabine—Oedema—Epirubicin—pancreatic cancer	2.87e-05	0.000416	CcSEcCtD
Fludarabine—Infection—Epirubicin—pancreatic cancer	2.85e-05	0.000413	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—BRCA2—pancreatic cancer	2.84e-05	0.000756	CbGpPWpGaD
Fludarabine—Cough—Doxorubicin—pancreatic cancer	2.83e-05	0.000411	CcSEcCtD
Fludarabine—DCK—Metabolism—GLP1R—pancreatic cancer	2.83e-05	0.000753	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—SRC—pancreatic cancer	2.82e-05	0.000748	CbGpPWpGaD
Fludarabine—Convulsion—Doxorubicin—pancreatic cancer	2.81e-05	0.000408	CcSEcCtD
Fludarabine—Nervous system disorder—Epirubicin—pancreatic cancer	2.81e-05	0.000408	CcSEcCtD
Fludarabine—Thrombocytopenia—Epirubicin—pancreatic cancer	2.81e-05	0.000407	CcSEcCtD
Fludarabine—DCK—Metabolism—DPYD—pancreatic cancer	2.79e-05	0.00074	CbGpPWpGaD
Fludarabine—Hyperhidrosis—Epirubicin—pancreatic cancer	2.77e-05	0.000402	CcSEcCtD
Fludarabine—Arthralgia—Doxorubicin—pancreatic cancer	2.77e-05	0.000401	CcSEcCtD
Fludarabine—Myalgia—Doxorubicin—pancreatic cancer	2.77e-05	0.000401	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—VEGFA—pancreatic cancer	2.74e-05	0.000729	CbGpPWpGaD
Fludarabine—POLA1—Mitotic M-M/G1 phases—RB1—pancreatic cancer	2.74e-05	0.000729	CbGpPWpGaD
Fludarabine—Discomfort—Doxorubicin—pancreatic cancer	2.73e-05	0.000396	CcSEcCtD
Fludarabine—Anorexia—Epirubicin—pancreatic cancer	2.73e-05	0.000396	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—TYMS—pancreatic cancer	2.71e-05	0.000719	CbGpPWpGaD
Fludarabine—Vomiting—Docetaxel—pancreatic cancer	2.7e-05	0.000392	CcSEcCtD
Fludarabine—Rash—Docetaxel—pancreatic cancer	2.68e-05	0.000388	CcSEcCtD
Fludarabine—Dermatitis—Docetaxel—pancreatic cancer	2.68e-05	0.000388	CcSEcCtD
Fludarabine—Confusional state—Doxorubicin—pancreatic cancer	2.67e-05	0.000388	CcSEcCtD
Fludarabine—RRM1—Metabolism—CD44—pancreatic cancer	2.66e-05	0.000707	CbGpPWpGaD
Fludarabine—Headache—Docetaxel—pancreatic cancer	2.66e-05	0.000386	CcSEcCtD
Fludarabine—Anaphylactic shock—Doxorubicin—pancreatic cancer	2.65e-05	0.000385	CcSEcCtD
Fludarabine—Oedema—Doxorubicin—pancreatic cancer	2.65e-05	0.000385	CcSEcCtD
Fludarabine—DCK—Metabolism—SLC2A2—pancreatic cancer	2.65e-05	0.000703	CbGpPWpGaD
Fludarabine—Infection—Doxorubicin—pancreatic cancer	2.63e-05	0.000382	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Epirubicin—pancreatic cancer	2.61e-05	0.000379	CcSEcCtD
Fludarabine—Nervous system disorder—Doxorubicin—pancreatic cancer	2.6e-05	0.000377	CcSEcCtD
Fludarabine—Thrombocytopenia—Doxorubicin—pancreatic cancer	2.6e-05	0.000376	CcSEcCtD
Fludarabine—Paraesthesia—Epirubicin—pancreatic cancer	2.57e-05	0.000373	CcSEcCtD
Fludarabine—Hyperhidrosis—Doxorubicin—pancreatic cancer	2.56e-05	0.000372	CcSEcCtD
Fludarabine—Dyspnoea—Epirubicin—pancreatic cancer	2.55e-05	0.00037	CcSEcCtD
Fludarabine—RRM1—Metabolism—GCG—pancreatic cancer	2.55e-05	0.000678	CbGpPWpGaD
Fludarabine—Anorexia—Doxorubicin—pancreatic cancer	2.53e-05	0.000367	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—MYC—pancreatic cancer	2.52e-05	0.000671	CbGpPWpGaD
Fludarabine—Nausea—Docetaxel—pancreatic cancer	2.52e-05	0.000366	CcSEcCtD
Fludarabine—Dyspepsia—Epirubicin—pancreatic cancer	2.52e-05	0.000366	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TGFB1—pancreatic cancer	2.52e-05	0.000669	CbGpPWpGaD
Fludarabine—Decreased appetite—Epirubicin—pancreatic cancer	2.49e-05	0.000361	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Epirubicin—pancreatic cancer	2.47e-05	0.000359	CcSEcCtD
Fludarabine—Fatigue—Epirubicin—pancreatic cancer	2.47e-05	0.000358	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—EGFR—pancreatic cancer	2.47e-05	0.000656	CbGpPWpGaD
Fludarabine—Constipation—Epirubicin—pancreatic cancer	2.45e-05	0.000355	CcSEcCtD
Fludarabine—Pain—Epirubicin—pancreatic cancer	2.45e-05	0.000355	CcSEcCtD
Fludarabine—Musculoskeletal discomfort—Doxorubicin—pancreatic cancer	2.42e-05	0.00035	CcSEcCtD
Fludarabine—RRM1—Metabolism—STK11—pancreatic cancer	2.4e-05	0.000637	CbGpPWpGaD
Fludarabine—Paraesthesia—Doxorubicin—pancreatic cancer	2.38e-05	0.000345	CcSEcCtD
Fludarabine—Dyspnoea—Doxorubicin—pancreatic cancer	2.36e-05	0.000343	CcSEcCtD
Fludarabine—Feeling abnormal—Epirubicin—pancreatic cancer	2.36e-05	0.000342	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—TERT—pancreatic cancer	2.36e-05	0.000626	CbGpPWpGaD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TNF—pancreatic cancer	2.35e-05	0.000625	CbGpPWpGaD
Fludarabine—Dyspepsia—Doxorubicin—pancreatic cancer	2.33e-05	0.000338	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—KRAS—pancreatic cancer	2.33e-05	0.00062	CbGpPWpGaD
Fludarabine—Decreased appetite—Doxorubicin—pancreatic cancer	2.3e-05	0.000334	CcSEcCtD
Fludarabine—Gastrointestinal disorder—Doxorubicin—pancreatic cancer	2.29e-05	0.000332	CcSEcCtD
Fludarabine—Fatigue—Doxorubicin—pancreatic cancer	2.29e-05	0.000331	CcSEcCtD
Fludarabine—Constipation—Doxorubicin—pancreatic cancer	2.27e-05	0.000329	CcSEcCtD
Fludarabine—Pain—Doxorubicin—pancreatic cancer	2.27e-05	0.000329	CcSEcCtD
Fludarabine—Body temperature increased—Epirubicin—pancreatic cancer	2.27e-05	0.000329	CcSEcCtD
Fludarabine—Feeling abnormal—Doxorubicin—pancreatic cancer	2.18e-05	0.000317	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—PIK3CA—pancreatic cancer	2.14e-05	0.000569	CbGpPWpGaD
Fludarabine—Hypersensitivity—Epirubicin—pancreatic cancer	2.11e-05	0.000306	CcSEcCtD
Fludarabine—Body temperature increased—Doxorubicin—pancreatic cancer	2.1e-05	0.000304	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—TP53—pancreatic cancer	2.07e-05	0.000551	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—TYMS—pancreatic cancer	2.06e-05	0.000548	CbGpPWpGaD
Fludarabine—Asthenia—Epirubicin—pancreatic cancer	2.06e-05	0.000298	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—RB1—pancreatic cancer	2.05e-05	0.000545	CbGpPWpGaD
Fludarabine—DCK—Metabolism—CD44—pancreatic cancer	2.05e-05	0.000544	CbGpPWpGaD
Fludarabine—Pruritus—Epirubicin—pancreatic cancer	2.03e-05	0.000294	CcSEcCtD
Fludarabine—DCK—Metabolism—GCG—pancreatic cancer	1.96e-05	0.000522	CbGpPWpGaD
Fludarabine—Diarrhoea—Epirubicin—pancreatic cancer	1.96e-05	0.000284	CcSEcCtD
Fludarabine—Hypersensitivity—Doxorubicin—pancreatic cancer	1.95e-05	0.000283	CcSEcCtD
Fludarabine—Asthenia—Doxorubicin—pancreatic cancer	1.9e-05	0.000276	CcSEcCtD
Fludarabine—Pruritus—Doxorubicin—pancreatic cancer	1.88e-05	0.000272	CcSEcCtD
Fludarabine—DCK—Metabolism—STK11—pancreatic cancer	1.85e-05	0.00049	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—RB1—pancreatic cancer	1.83e-05	0.000487	CbGpPWpGaD
Fludarabine—Vomiting—Epirubicin—pancreatic cancer	1.82e-05	0.000264	CcSEcCtD
Fludarabine—Diarrhoea—Doxorubicin—pancreatic cancer	1.81e-05	0.000263	CcSEcCtD
Fludarabine—Rash—Epirubicin—pancreatic cancer	1.81e-05	0.000262	CcSEcCtD
Fludarabine—Dermatitis—Epirubicin—pancreatic cancer	1.81e-05	0.000262	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—CDKN2A—pancreatic cancer	1.8e-05	0.000479	CbGpPWpGaD
Fludarabine—Headache—Epirubicin—pancreatic cancer	1.8e-05	0.00026	CcSEcCtD
Fludarabine—POLA1—Integrated Pancreatic Cancer Pathway—AKT1—pancreatic cancer	1.75e-05	0.000465	CbGpPWpGaD
Fludarabine—Nausea—Epirubicin—pancreatic cancer	1.7e-05	0.000247	CcSEcCtD
Fludarabine—Vomiting—Doxorubicin—pancreatic cancer	1.69e-05	0.000244	CcSEcCtD
Fludarabine—RRM1—Metabolism—APOE—pancreatic cancer	1.68e-05	0.000446	CbGpPWpGaD
Fludarabine—Rash—Doxorubicin—pancreatic cancer	1.67e-05	0.000242	CcSEcCtD
Fludarabine—Dermatitis—Doxorubicin—pancreatic cancer	1.67e-05	0.000242	CcSEcCtD
Fludarabine—Headache—Doxorubicin—pancreatic cancer	1.66e-05	0.000241	CcSEcCtD
Fludarabine—POLA1—Cell Cycle—CDKN2A—pancreatic cancer	1.61e-05	0.000428	CbGpPWpGaD
Fludarabine—DCK—Metabolism—TYMS—pancreatic cancer	1.59e-05	0.000422	CbGpPWpGaD
Fludarabine—Nausea—Doxorubicin—pancreatic cancer	1.57e-05	0.000228	CcSEcCtD
Fludarabine—POLA1—Cell Cycle, Mitotic—CCND1—pancreatic cancer	1.52e-05	0.000405	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CG—pancreatic cancer	1.51e-05	0.000402	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PPARG—pancreatic cancer	1.46e-05	0.000388	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—CCND1—pancreatic cancer	1.36e-05	0.000362	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CD—pancreatic cancer	1.33e-05	0.000354	CbGpPWpGaD
Fludarabine—DCK—Metabolism—APOE—pancreatic cancer	1.29e-05	0.000343	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle, Mitotic—MYC—pancreatic cancer	1.22e-05	0.000325	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CG—pancreatic cancer	1.17e-05	0.00031	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CB—pancreatic cancer	1.16e-05	0.000308	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTGS2—pancreatic cancer	1.15e-05	0.000306	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PPARG—pancreatic cancer	1.13e-05	0.000299	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—MYC—pancreatic cancer	1.09e-05	0.00029	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CD—pancreatic cancer	1.02e-05	0.000272	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PTEN—pancreatic cancer	1e-05	0.000266	CbGpPWpGaD
Fludarabine—POLA1—Cell Cycle—TP53—pancreatic cancer	8.98e-06	0.000238	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CB—pancreatic cancer	8.93e-06	0.000237	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PTGS2—pancreatic cancer	8.85e-06	0.000235	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PTEN—pancreatic cancer	7.72e-06	0.000205	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—PIK3CA—pancreatic cancer	7.08e-06	0.000188	CbGpPWpGaD
Fludarabine—RRM1—Metabolism—AKT1—pancreatic cancer	5.78e-06	0.000154	CbGpPWpGaD
Fludarabine—DCK—Metabolism—PIK3CA—pancreatic cancer	5.45e-06	0.000145	CbGpPWpGaD
Fludarabine—DCK—Metabolism—AKT1—pancreatic cancer	4.45e-06	0.000118	CbGpPWpGaD
